Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2026-02-23 @ 2:21 AM
Study NCT ID:
NCT02996461
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
2016-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-12
Start Date Type:
None
Primary Completion Date:
2019-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-16
First Submit QC Date:
None
Study First Post Date:
2016-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-14
Last Update Post Date:
2019-12-17
Last Update Post Date Type:
ACTUAL